Clinical Scorecard: Molecular Mechanisms of Dihuang Yinzi in Managing Diabetic Retinopathy: Insights from Network Pharmacology, Metabolomics, and Microbiome Studies

At a Glance

Key Highlights

• Identification of 110 candidate genes related to diabetic retinopathy.
• Five primary target genes: STAT3, IL6, TNF, ESR1, and IL1B.
• Molecular docking revealed strong binding affinity of naringenin to ESR1.
• Assessment identified 50 candidate metabolites and 24 candidate microbes.
• Spearman correlation analysis highlighted 30 key metabolites and 18 key microbes.

Guideline-Based Recommendations

Diagnosis

• Utilize metabolomic and microbiome assessments for comprehensive evaluation.

Management

• Consider Dihuang Yinzi as a therapeutic option for diabetic retinopathy.

Monitoring & Follow-up

• Regularly assess key metabolites and microbial taxa for treatment efficacy.

Risks

• Monitor for potential adverse effects associated with herbal treatments.

Patient & Prescribing Data

Individuals diagnosed with diabetic retinopathy.

Dihuang Yinzi may provide a multi-targeted approach to managing diabetic retinopathy.

Clinical Best Practices

• Integrate multi-omics approaches in understanding treatment mechanisms.
• Utilize computational algorithms for identifying target genes in treatment.

Related Resources & Content

• Molecular Mechanisms of Dihuang Yinzi in Managing Diabetic Retinopathy